Cryo-Cell International Overview

  • Founded
  • 1989
Founded
  • Status
  • Public
  • Employees
  • 98
Employees
  • Stock Symbol
  • CCEL
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $12.69
  • (As of Monday Closing)

Cryo-Cell International General Information

Description

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. It organized in three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Healthcare Services
Stock Exchange
NAS
Primary Office
  • 700 Brooker Creek Boulevard
  • Suite 1800
  • Oldsmar, FL 34677
  • United States
+1 (813) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cryo-Cell International Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$12.69 $13.15 $6.45 - $14.16 $112M 8.53M 6.4K $0.50

Cryo-Cell International Financials Summary

In Thousands,
USD
TTM 31-May-2021 FY 2020 30-Nov-2020 FY 2019 30-Nov-2019 FY 2018 30-Nov-2018
EV 62,869 55,486 58,198 63,801
Revenue 29,721 31,148 31,817 29,218
EBITDA 7,636 7,219 5,496 5,482
Net Income 3,849 3,625 2,291 (855)
Total Assets 58,318 46,200 42,886 42,390
Total Debt 4,497 6,240 8,956 12,944
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cryo-Cell International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cryo-Cell International‘s full profile, request access.

Request a free trial

Cryo-Cell International Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. It organized in three reportable se
Other Healthcare Services
Oldsmar, FL
98 As of 2020
00000
000000&0

00000000

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
0000000000 00000000 (0000000000)
Cedar Knolls, NJ
00 As of 0000
00000
000000&0

0000 000

qua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commod
00000 000000000000000 000 0000000000000
Los Angeles, CA
000 As of 0000
00000
0000 0000-00-00
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cryo-Cell International Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LifebankUSA Corporate Backed or Acquired Cedar Knolls, NJ 00 00000 000000&0
0000 00000 0000000 Private Equity-Backed Los Angeles, CA 000 00000 000000000000
00000000 000000000 Venture Capital-Backed Chennai, India 0000 00.000 0000000000 0 00.000
00000000 Venture Capital-Backed Baldwin Park, CA 000 000.00 00000 00000 000.00
To view Cryo-Cell International’s complete competitors history, request access »

Cryo-Cell International Patents

Cryo-Cell International Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2013523774-A Cell therapy to improve wound healing and related compositions and methods Withdrawn 01-Apr-2010 000000000
CA-2795248-A1 Cell therapy to improve wound healing and related compositions and methods Abandoned 01-Apr-2010 000000000
EP-2553089-A1 Cell therapy to improve wound healing and related compositions and methods Withdrawn 01-Apr-2010 000000000 0
EP-2553089-A4 Cell therapy to improve wound healing and related compositions and methods Withdrawn 01-Apr-2010 000000000 0
US-20090191628-A1 Methods for co-culturing cord blood derived cells with menstrual stem cells Abandoned 31-Oct-2007 C12N5/0647 0

Cryo-Cell International Executive Team (7)

Name Title Board Seat Contact Info
David Portnoy Chairman & Chief Executive Officer
Mark Portnoy Chief Executive Officer & Board Member
Jill Taymans Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Oleg Mikulinsky Chief Information Officer
Linda Kelley Ph.D Chief Scientific Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Cryo-Cell International Board Members (8)

Name Representing Role Since
0000000 00000 00 Self Board Member 000 0000
00000 0000000 Cryo-Cell International Chairman & Chief Executive Officer 000 0000
000000 000000 00. Cryo-Cell International Board Member 000 0000
000000 000000 Cryo-Cell International Board Member 000 0000
00000000 0000000 00 Cryo-Cell International Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Cryo-Cell International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cryo-Cell International Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cryo-Cell International‘s full profile, request access.

Request a free trial

Cryo-Cell International Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000:000 0000 0000 29-May-2018 000000000000000000 0000 Other Healthcare Services 00000 0000000
00000000000 000000 30-Jun-2015 000000000000000000 00.00 Biotechnology 00000 0000000
Cord Blood America 10-Mar-2015 PIPE Biotechnology 00000 0000000
To view Cryo-Cell International’s complete investments and acquisitions history, request access »

Cryo-Cell International Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 00000 0000000 10-Mar-2015 0000 Completed
  • 0000-0000 00000000
To view Cryo-Cell International’s complete exits history, request access »